Ancajas gets COVID-19 vaccine ahead of title defense in US | Inquirer Sports

Ancajas gets COVID-19 vaccine ahead of title defense in US

By: - Reporter / @MarkGiongcoINQ
/ 07:55 PM March 24, 2021

Jerwin Ancajas boxing

Champion boxer Jerwin Ancajas. Photo by Tristan Tamayo/INQUIRER.net

MANILA, Philippines — Filipino boxing champion Jerwin Ancajas has been vaccinated against COVID-19.

Ancajas along with his entire team received a Pfizer jab ahead of the IBF super flyweight champion’s April 10 title defense in the United States.

Article continues after this advertisement

“Us, coach Joven have already been vaccinated,” Ancajas bared in Filipino during a recent virtual press conference.

FEATURED STORIES

The 29-year-old Panabo, Davao Del Norte native is defending his crown for the ninth time when he meets Jonathan Rodriguez of Mexico (22-1, 16 KOs) at Mohegan Sun Arena in Uncasville, Connecticut.

The bout had already been pushed back twice. It was re-set from November 2019 to April 2020 but failed to push through due to the COVID-19 pandemic.

Article continues after this advertisement

Despite the delays, Ancajas vowed he remains focused for his first fight in over a year.

Ancajas (32-1-2, 22 KOs) has been training in the US at Freddie Roach’s Wild Card Gym since October.

RELATED STORIES

Ancajas has sights on Rungvisai, not looking past April bout

Ancajas raring for fight after series of delays

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Boxing, covid-19 vaccine, Jerwin Ancajas, Jonathan Rodriguez, pandemic, super flyweight

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.